Home › Urinary Retention › NCT05657990
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
RecruitingEarly phase 1
Who can join
Ages 55 and older · Men
Full eligibility criteria
Inclusion Criteria: * Males * ≥55 years old * Planned thoracic oncological surgical procedure of a video assisted oncological surgical procedure for suspected or confirmed cancer. * Surgery scheduled more than 7 days from the time of consent Exclusion Criteria: * Using Tamsulosin already * Known allergy to Tamsulosin or sulfa drugs * Current use of Boceprevir * Resting systolic blood pressure \<100 * Orthostatic hypotension of \>20mm Hg systolic and/or 10mm Hg diastolic pressure from sitting to standing (after 2 minutes of standing) as measured at the time of consent * Known history of hypotension * Known diagnosis of congestive heart failure (CHF) and valvular heart disease * History of prior prostate surgery (prostatectomy, trans-urethral resection)
About the study
This is a feasibility study looking at whether the use of Tamsulosin could lower the high incidence of postoperative urinary retention (POUR) in older men who undergo an oncological thoracic surgical procedure for suspected or confirmed cancer. In addition, the study will try to identify the time of resumption of presurgical urinary function post Tamsulosin administration.
What is being tested
- Tamsulosin (drug)
Sponsor: Hackensack Meridian Health · Participants: 46 · Started: Apr 3, 2023
Contact the study team
- Denise Theiler, RN · Phone: 7327763301
Official record on ClinicalTrials.gov — NCT05657990
Locations in the U.S.
| New Jersey | Ocean University Medical Center, Brick South Ocean University Medical Center, Manahawkin Jersey Shore University Medical Center, Neptune City Riverview Medical Center, Red Bank |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.